Immunoglobulin lambda-like polypeptide 1

BE0009059ProteinHumansIGLL1

Critical for B-cell development. It is acted on by 1 drug in DrugBank.

Gene name
IGLL1
UniProtKB entry
P15814Swiss-Prot
Cellular location
Endoplasmic reticulum
Residues / weight
213 residues · 22,963 Da
Also known as
CD179 antigen-like family member B · Ig lambda-5 · IGL1 · Immunoglobulin omega polypeptide · Immunoglobulin-related protein 14.1

Resolves to

Protein
UniProtP15814UniProt nameIGLL1_HUMAN
Gene
HGNCHGNC:5870NCBI Gene3543GeneCardsIGLL1
Pharmacology
KEGGhsa:3543
Structure
PDB2H32PDB2H3NPDB2LKQ
Drugs

What you can answer from here — as of September 07, 2019

1DrugApproved to experimental, with action, bond type and pharmacological action
Sign in
3GO termsFunction, process and component, as structured annotations
Sign in
1Pfam domainDomain architecture mapped to Pfam families and clans
Sign in
9+ReferencesStructured and connected to the statements they support
Sign in

Which approved drugs act on Immunoglobulin lambda-like polypeptide 1, how selective are they, and which programs against it are still in active trials?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In